Royalty Pharma Plc (RPRX)
38.08
-0.58
(-1.51%)
USD |
NASDAQ |
Dec 09, 16:00
38.17
+0.08
(+0.22%)
After-Hours: 20:00
Royalty Pharma Free Cash Flow: 1.048B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Denali Therapeutics, Inc. | -410.85M |
| Amgen, Inc. | 11.54B |
| Eli Lilly & Co. | 6.436B |
| Zenas BioPharma, Inc. | -158.56M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 703.52M |
| Cash from Investing (Quarterly) | -959.42M |
| Cash from Financing (Quarterly) | 562.94M |
| Free Cash Flow Per Share (Quarterly) | -0.4617 |
| Free Cash Flow to Equity (Quarterly) | -1.201B |
| Free Cash Flow to Firm (Quarterly) | -178.79M |
| Free Cash Flow Yield | 4.81% |